Analysis BioNTech’s Double Play: Cancer Vaccine Milestone and a New Legal Front Against Moderna
The German biotech is making headlines on two fronts this week — one that underscores its long-term oncology ambitions, and another that signals an increasingly aggressive posture in the courtroom....